Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
Morani G, Gasparini M, Zanon F, Casali E, Spotti A, Reggiani A, Bertaglia E, Solimene F, Molon G, Accogli M, Tommasi C, Paoletti Perini A, Ciardiello C, Padeletti L. Morani G, et al. Europace. 2013 Sep;15(9):1273-9. doi: 10.1093/europace/eut032. Epub 2013 Feb 24. Europace. 2013. PMID: 23439866
Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
Ricci RP, Pignalberi C, Landolina M, Santini M, Lunati M, Boriani G, Proclemer A, Facchin D, Catanzariti D, Morani G, Gulizia M, Mangoni L, Grammatico A, Gasparini M; ClinicalService cardiological centres. Ricci RP, et al. Among authors: morani g. Heart. 2014 Jun;100(11):848-54. doi: 10.1136/heartjnl-2013-305259. Epub 2014 Mar 28. Heart. 2014. PMID: 24682569 Clinical Trial.
Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.
Boriani G, Manolis AS, Tukkie R, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, Gulizia M, Samoilenko IV, Wolff C, Holbrook R, Gavazza F, Padeletti L; MINERVA Investigators. Boriani G, et al. Heart Rhythm. 2015 Jun;12(6):1192-200. doi: 10.1016/j.hrthm.2015.02.017. Epub 2015 Feb 19. Heart Rhythm. 2015. PMID: 25701774 Clinical Trial.
Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
Landolina M, Curnis A, Morani G, Vado A, Ammendola E, D'onofrio A, Stabile G, Crosato M, Petracci B, Ceriotti C, Bontempi L, Morosato M, Ballari GP, Gasparini M. Landolina M, et al. Among authors: morani g. Europace. 2015 Aug;17(8):1251-8. doi: 10.1093/europace/euv109. Epub 2015 May 14. Europace. 2015. PMID: 25976906 Free PMC article.
Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality.
Landolina M, Lunati M, Boriani G, Pietro Ricci R, Proclemer A, Facchin D, Rordorf R, Morani G, Maines M, Gasparini G, Molon G, Turrini P, Gasparini M; ClinicalService cardiological centers. Landolina M, et al. Among authors: morani g. Heart Rhythm. 2016 Feb;13(2):472-80. doi: 10.1016/j.hrthm.2015.10.022. Epub 2015 Oct 23. Heart Rhythm. 2016. PMID: 26477710 Clinical Trial.
Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study.
D'Onofrio A, Stabile G, Capucci A, Amellone C, De Simone A, Leoni L, Morani G, Bianchi V, Campari M, Valsecchi S, Buja G; EFFECT study investigators. D'Onofrio A, et al. Among authors: morani g. J Telemed Telecare. 2016 Oct;22(7):383-90. doi: 10.1177/1357633X15613701. Epub 2015 Dec 24. J Telemed Telecare. 2016. PMID: 26703214 Clinical Trial.
The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.
Landolina M, Morani G, Curnis A, Vado A, D'Onofrio A, Bianchi V, Stabile G, Crosato M, Petracci B, Ceriotti C, Bontempi L, Morosato M, Ballari GP, Gasparini M. Landolina M, et al. Among authors: morani g. Europace. 2017 Aug 1;19(8):1349-1356. doi: 10.1093/europace/euw176. Europace. 2017. PMID: 27702861 Free PMC article.
63 results